Shares

44 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2024

BUY
$4.86 - $5.83 $163,271 - $195,858
33,595 New
33,595 $179,000
Q3 2023

Nov 13, 2023

SELL
$4.86 - $5.83 $163,271 - $195,858
-33,595 Closed
0 $0
Q2 2023

Aug 14, 2024

BUY
$4.48 - $5.53 $150,505 - $185,780
33,595 New
33,595 $177,000
Q2 2023

Aug 14, 2023

SELL
$4.48 - $5.53 $150,505 - $185,780
-33,595 Closed
0 $0
Q1 2023

May 15, 2024

BUY
$4.12 - $5.25 $138,411 - $176,373
33,595 New
33,595 $155,000
Q4 2022

Feb 14, 2023

BUY
$3.79 - $4.84 $127,325 - $162,599
33,595 New
33,595 $134,000
Q3 2022

Nov 13, 2023

BUY
$4.42 - $5.43 $148,489 - $182,420
33,595 New
33,595 $151,000
Q2 2022

Aug 14, 2023

BUY
$4.22 - $5.85 $141,770 - $196,530
33,595 New
33,595 $151,000
Q1 2022

May 09, 2022

SELL
$5.43 - $6.81 $182,420 - $228,781
-33,595 Closed
0 $0
Q4 2021

Mar 09, 2022

BUY
$5.21 - $6.82 $175,029 - $229,117
33,595 New
33,595 $222,000
Q3 2021

Nov 14, 2022

BUY
$5.25 - $5.87 $176,373 - $197,202
33,595 New
33,595 $178,000
Q3 2021

Nov 05, 2021

SELL
$5.25 - $5.87 $176,373 - $197,202
-33,595 Closed
0 $0
Q2 2021

Aug 15, 2022

BUY
$5.67 - $6.33 $190,483 - $212,656
33,595 New
33,595 $197,000
Q2 2021

Aug 10, 2021

SELL
$5.67 - $6.33 $527,474 - $588,873
-93,029 Closed
0 $0
Q1 2021

May 09, 2022

BUY
$6.02 - $8.06 $560,034 - $749,813
93,029 New
93,029 $569,000
Q1 2021

May 07, 2021

SELL
$6.02 - $8.06 $2 Million - $2.67 Million
-331,663 Closed
0 $0
Q4 2020

Mar 02, 2021

BUY
$6.3 - $8.46 $2.09 Million - $2.81 Million
331,663 New
331,663 $2.13 Million
Q4 2020

Feb 10, 2021

SELL
$6.3 - $8.46 $2.09 Million - $2.81 Million
-331,663 Closed
0 $0
Q3 2020

Nov 12, 2021

BUY
$8.02 - $11.73 $2.66 Million - $3.89 Million
331,663 New
331,663 $2.84 Million
Q3 2020

Nov 10, 2020

SELL
$8.02 - $11.73 $3.06 Million - $4.48 Million
-381,963 Closed
0 $0
Q2 2020

Aug 13, 2021

BUY
$5.37 - $9.45 $2.05 Million - $3.61 Million
381,963 New
381,963 $2.92 Million
Q2 2020

Aug 07, 2020

SELL
$5.37 - $9.45 $2.05 Million - $3.61 Million
-381,963 Closed
0 $0
Q1 2020

May 07, 2021

BUY
$4.56 - $7.13 $1.74 Million - $2.72 Million
381,963 New
381,963 $2.32 Million
Q1 2020

May 08, 2020

SELL
$4.56 - $7.13 $1.82 Million - $2.85 Million
-399,446 Closed
0 $0
Q4 2019

Mar 03, 2020

BUY
$4.97 - $7.7 $1.99 Million - $3.08 Million
399,446 New
399,446 $2.74 Million
Q4 2019

Feb 12, 2020

SELL
$4.97 - $7.7 $218,143 - $337,968
-43,892 Closed
0 $0
Q3 2019

Nov 13, 2020

BUY
$5.11 - $5.99 $224,288 - $262,913
43,892 New
43,892 $226,000
Q3 2019

Nov 08, 2019

SELL
$5.11 - $5.99 $224,288 - $262,913
-43,892 Closed
0 $0
Q2 2019

Aug 13, 2020

BUY
$5.39 - $6.26 $236,577 - $274,763
43,892 New
43,892 $237,000
Q2 2019

Aug 09, 2019

SELL
$5.39 - $6.26 $236,577 - $274,763
-43,892 Closed
0 $0
Q4 2018

Mar 04, 2019

BUY
$4.68 - $6.25 $205,414 - $274,325
43,892 New
43,892 $219,000
Q4 2018

Feb 08, 2019

SELL
$4.68 - $6.25 $170,600 - $227,831
-36,453 Closed
0 $0
Q3 2018

Nov 12, 2019

BUY
$5.15 - $6.3 $187,732 - $229,653
36,453 New
36,453 $225,000
Q3 2018

Nov 09, 2018

SELL
$5.15 - $6.3 $187,732 - $229,653
-36,453 Closed
0 $0
Q2 2018

Aug 12, 2019

BUY
$4.4 - $5.3 $160,393 - $193,200
36,453 New
36,453 $188,000
Q2 2018

Jul 23, 2018

SELL
$4.4 - $5.3 $160,393 - $193,200
-36,453 Closed
0 $0
Q1 2018

May 15, 2019

BUY
$4.6 - $5.75 $167,683 - $209,604
36,453 New
36,453 $167,000
Q1 2018

May 09, 2018

SELL
$4.6 - $5.75 $167,683 - $209,604
-36,453 Closed
0 $0
Q4 2017

Mar 05, 2018

BUY
$4.35 - $5.15 $158,570 - $187,732
36,453 New
36,453 $171,000
Q4 2017

Feb 09, 2018

SELL
$4.35 - $5.15 $281,714 - $333,524
-64,762 Closed
0 $0
Q3 2017

Nov 13, 2018

BUY
$4.25 - $4.8 $275,238 - $310,857
64,762 New
64,762 $312,000
Q3 2017

Nov 07, 2017

SELL
$4.25 - $4.8 $275,238 - $310,857
-64,762 Closed
0 $0
Q1 2017

May 11, 2018

SELL
N/A
-4,031 Reduced 5.86%
64,762 $450,000
Q3 2016

Nov 13, 2017

BUY
N/A
68,793
68,793 $0

Others Institutions Holding KMDA

About KAMADA LTD


  • Ticker KMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 44,800,500
  • Market Cap $264M
  • Description
  • Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...
More about KMDA
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.